PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Novozymes A/s

USPTO PatentsView assignee record - 770 granted patents across 73 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

Explore the portfolio See the ranking
770
Total patents granted
73
CPC technology areas
18.7
Avg claims per patent
+4%
5-year filing velocity

The verdict

Novozymes holds 770 US patents across 73 technology areas, rank #581 of 50,000 tracked assignees.

#581
of 50,000 US assignees by volume
Top 2%
by Innovation Score (63.6/100)
18.7
avg claims per patent
+4%
filing velocity, last 5 yrs

Portfolio overview

Novozymes A/s has been granted 770 US utility patents between 2015 and 2025, placing Novozymes A/s at rank #581 across all assignees tracked by PlainPatent. This portfolio spans 73 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.7 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Novozymes A/s is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Novozymes sits between Mitsubishi Electric Research Laboratories, Inc. (780 patents, rank #577) and Medtronic Minimed, Inc. (769 patents, rank #585) - the closest US assignees by grant volume. The composite Innovation Score of 63.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 392 grants, compared with 378 in the 2015–2019 window, a +4% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Novozymes A/s's 18.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 73 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Novozymes A/s against peers pursuing similar technology classes.

Who files at Novozymes's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Novozymes holds 770 patents at rank #581, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Novozymes

By rank, the assignees closest to #581 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Novozymes's primary technology class.

Novozymes's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

64 Top 2% higher than 98% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

20406080100120 20152016201720182019202020212022202320242025 42
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Novozymes A/s patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 48 6.2%
2016 79 10.3%
2017 85 11.0%
2018 80 10.4%
2019 86 11.2%
2020 98 12.7%
2021 79 10.3%
2022 66 8.6%
2023 49 6.4%
2024 58 7.5%
2025 42 5.5%

Which technologies does Novozymes A/s patent most?

Top 15 of 73 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#581

Across all tracked assignees

Innovation Score

63.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Novozymes A/s hold?
Novozymes A/s holds 770 US granted patents filed between 2015 and 2025, spanning 73 technology areas.
What is Novozymes A/s's Innovation Score?
Novozymes A/s has an Innovation Score of 63.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Novozymes A/s focus on?
Novozymes A/s's top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 656 patents. The company has filed patents in 73 CPC subclasses total.
Is Novozymes A/s's patent filing rate increasing or decreasing?
Novozymes A/s's recent filing velocity is +4% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Novozymes A/s's patents?
Novozymes A/s's patents average 18.7 claims each. This falls within the standard range, providing solid legal coverage.
How is the Novozymes A/s patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Novozymes's 770 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Novozymes ranks #581 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.